NOYES TIMOTHY P

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
26
Insider Sells Sum
$6.43M

Insider Activity of NOYES TIMOTHY P

According to the SEC Form 4 filings, NOYES TIMOTHY P, being in a position of

  1. CHIEF EXECUTIVE OFFICER at Aerovate Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 41357 shares for $993,705,
    over all time since 2022-11-01, has bought 0 shares, and sold 275206 shares for $6.09M.

The largest sale of all time was on 2023-01-03 and amounted to 30000 shares of Aerovate Therapeutics, Inc. for $812,152.

Biography of NOYES TIMOTHY P

No biography is available at this moment.

2024-05-16SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
10,000
0.0347%
$21.58$215,755-90.28%
2024-05-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
11,357
0.0386%
$20.34$230,946-88.72%
2024-04-16SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
10,000
0.0375%
$24.70$246,971-89.29%
2024-04-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
10,000
0.035%
$30.00$300,033-91.67%
2023-11-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
1,092
0.0039%
$10.42$11,379+75.66%
2023-07-28SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
5,478
0.024%
$18.00$98,604+1.55%
2023-07-17SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
4,522
0.0203%
$18.11$81,896+7.12%
2023-07-03SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
10,000
0.0394%
$18.00$180,000-4.12%
2023-05-02SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
693
0.0029%
$21.15$14,657-17.35%
2023-05-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
15,000
0.0597%
$20.61$309,089-18.91%
2023-04-03SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
15,000
0.061%
$19.39$290,916-12.41%
2023-03-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
15,000
0.065%
$23.81$357,196-23.72%
2023-03-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
30,000
0.1299%
$23.81$714,393-23.72%
2023-03-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
13,950
0.0601%
$23.67$330,243-23.72%
2023-02-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
15,000
0.0603%
$22.68$340,197-25.87%
2023-02-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
30,000
0.1207%
$22.68$680,394-25.87%
2023-01-03SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
30,000
0.1228%
$27.07$812,152-36.81%
2022-12-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
15,000
0.0599%
$18.00$270,000-5.32%
2022-12-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
30,000
0.1198%
$18.00$540,000-5.32%
2022-11-01SaleAerovate Therapeutics, Inc.
AVTE
CHIEF EXECUTIVE OFFICER
1,038
0.0043%
$19.50$20,241-5.71%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.